As the deadline for 2025 approaches, the corporate significance of Diversity, Equity, Inclusion, and Belonging (DEI&B) is increasingly acknowledged as vital for long-term business success. Research shows that companies with strong DEI&B initiatives benefit not only from higher financial performance but also through improved employee satisfaction, retention, and innovation, wrote former CIO Cletis Earle in this article. Organizations with diverse management teams see significant revenue boosts from innovation, while inclusive cultures foster productivity and customer satisfaction. However, some businesses, influenced by political and economic factors, have begun retracting DEI initiatives, raising concerns about the potential negative impact on organizational growth and reputation.

DEI&B: The Key to Business Success as 2025 Approaches Starbridge Advisors

Rady Children’s Health will officially launch on January 1, 2025, as a result of the merger between Children’s Hospital of Orange County (CHOC) and Rady Children’s Hospital San Diego, following approval from the California Office of the Attorney General. The new healthcare system aims to enhance pediatric care across Southern California by improving patient outcomes and promoting health equity, building on a longstanding partnership between the two hospitals. Leadership will be jointly held by CHOC’s Kimberly Chavalas Cripe and Rady’s Patrick A. Frias, MD, focusing on patient care, education, and research while integrating their resources with the University of California's medical schools. The new system will comprise three hospitals: CHOC Hospital in Orange, CHOC at Mission Hospital in Mission Viejo, and Rady Children’s Hospital in San Diego.

CHOC and Rady Children’s Merge to Create Advanced Pediatric Healthcare System Inside CHOC

Children’s National Hospital and the FDA have initiated a five-year collaboration to address challenges in developing medical devices for children and infants. The partnership will create regulatory science tools using de-identified clinical data, multimodal imaging, and machine learning to enhance the evaluation and testing of pediatric devices. Currently, there is a significant gap in high-risk devices specifically designed for pediatric use, resulting in off-label usage and safety concerns. The initiative seeks to close this gap by providing open-source resources, as the current lack of regulatory incentives for pediatric medical devices has hindered innovation in the field.

FDA and Children’s National Hospital Join Forces to Advance Pediatric Device Innovation MedTech Dive

Kaiser Permanente has appointed Dr. Daniel Yang as its vice president of artificial intelligence and emerging technologies to lead AI initiatives across its healthcare network. Previously with the Gordon and Betty Moore Foundation, Dr. Yang aims to ensure quality oversight of AI applications in clinical operations, research, and education, while promoting a responsible AI culture focused on patient safety. He advocates for AI as a tool to improve access to care and address provider burnout, emphasizing the need for leaders with clinical and operational expertise to effectively communicate between technical teams and healthcare providers. One notable project under his leadership is the development of an AI-enabled clinical documentation tool aimed at reducing administrative burdens on physicians.

Kaiser Permanente Appoints Dr. Daniel Yang to Lead AI Innovations Healthcare IT News

As the deadline for 2025 approaches, the corporate significance of Diversity, Equity, Inclusion, and Belonging (DEI&B) is increasingly acknowledged as vital for long-term business success. Research shows that companies with strong DEI&B initiatives benefit not only from higher financial performance but also through improved employee satisfaction, retention, and innovation, wrote former CIO Cletis Earle in this article. Organizations with diverse management teams see significant revenue boosts from innovation, while inclusive cultures foster productivity and customer satisfaction. However, some businesses, influenced by political and economic factors, have begun retracting DEI initiatives, raising concerns about the potential negative impact on organizational growth and reputation.

DEI&B: The Key to Business Success as 2025 Approaches Starbridge Advisors

Rady Children’s Health will officially launch on January 1, 2025, as a result of the merger between Children’s Hospital of Orange County (CHOC) and Rady Children’s Hospital San Diego, following approval from the California Office of the Attorney General. The new healthcare system aims to enhance pediatric care across Southern California by improving patient outcomes and promoting health equity, building on a longstanding partnership between the two hospitals. Leadership will be jointly held by CHOC’s Kimberly Chavalas Cripe and Rady’s Patrick A. Frias, MD, focusing on patient care, education, and research while integrating their resources with the University of California's medical schools. The new system will comprise three hospitals: CHOC Hospital in Orange, CHOC at Mission Hospital in Mission Viejo, and Rady Children’s Hospital in San Diego.

CHOC and Rady Children’s Merge to Create Advanced Pediatric Healthcare System Inside CHOC

Children’s National Hospital and the FDA have initiated a five-year collaboration to address challenges in developing medical devices for children and infants. The partnership will create regulatory science tools using de-identified clinical data, multimodal imaging, and machine learning to enhance the evaluation and testing of pediatric devices. Currently, there is a significant gap in high-risk devices specifically designed for pediatric use, resulting in off-label usage and safety concerns. The initiative seeks to close this gap by providing open-source resources, as the current lack of regulatory incentives for pediatric medical devices has hindered innovation in the field.

FDA and Children’s National Hospital Join Forces to Advance Pediatric Device Innovation MedTech Dive

Kaiser Permanente has appointed Dr. Daniel Yang as its vice president of artificial intelligence and emerging technologies to lead AI initiatives across its healthcare network. Previously with the Gordon and Betty Moore Foundation, Dr. Yang aims to ensure quality oversight of AI applications in clinical operations, research, and education, while promoting a responsible AI culture focused on patient safety. He advocates for AI as a tool to improve access to care and address provider burnout, emphasizing the need for leaders with clinical and operational expertise to effectively communicate between technical teams and healthcare providers. One notable project under his leadership is the development of an AI-enabled clinical documentation tool aimed at reducing administrative burdens on physicians.

Kaiser Permanente Appoints Dr. Daniel Yang to Lead AI Innovations Healthcare IT News